The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 28, 2020

Filed:

Sep. 06, 2017
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Jeffrey D. Esko, San Diego, CA (US);

Yitzhak Tor, San Diego, CA (US);

Wenyong Tong, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); A61K 47/48 (2006.01); A61K 47/62 (2017.01); A61K 47/55 (2017.01); A61K 9/00 (2006.01); A61K 39/395 (2006.01); A61K 47/66 (2017.01); A61K 38/47 (2006.01);
U.S. Cl.
CPC ...
A61K 47/67 (2017.08); A61K 9/0043 (2013.01); A61K 38/46 (2013.01); A61K 38/47 (2013.01); A61K 39/39533 (2013.01); A61K 47/552 (2017.08); A61K 47/62 (2017.08); C12Y 302/01076 (2013.01); C12Y 310/01001 (2013.01);
Abstract

This disclosure relates to intranasal administration of conjugates comprising guanidinylated aminoglycosides ('guanidinoglycosides') and a polypeptide (e.g., an enzyme, antibody, or polypeptide growth factor). For example, such administration methods are useful for delivering a polypeptide to the brain and/or cerebrospinal fluid. Such methods are useful for treating a lysosomal storage disease through intranasal administration of a conjugate comprising one or more guanidinoglycosides and an enzyme useful for treating a lysosomal storage disease.


Find Patent Forward Citations

Loading…